CDH1 and neoplasm: Results of previous studies have demonstrated that the PI3K/Akt/mTOR and MAPK pathways in ovarian cancer affect cell metastasis through regulating the expression of E-cadherin, CAM, MMP and tumor angiogenic factors [41–44].